Description

The Hepatic Fibrosis Test YRA317 // YRA321 is an essential tool for the early detection and management of liver fibrosis, a condition that can significantly impact patient health if left untreated. This test, compatible with Chemiluminescence Immunoassay Analyzers YR06389 and YR06390, allows for the early identification of hepatic fibrosis, providing a window of opportunity for healthcare professionals to intervene before the condition progresses to cirrhosis, which is considerably more challenging to reverse. By utilizing this test, patients can maintain a better quality of life through timely treatment.

Market Price

The pricing of hepatic fibrosis tests like the YRA317 and YRA321 varies depending on the supplier and purchase quantity. Typically, the market price ranges from $300 to $600 per test kit. For detailed pricing and special offers, we recommend requesting a personalized quote to fit specific requirements and volumes.

Frequently Asked Questions

What is hepatic fibrosis? Hepatic fibrosis is the scarring process that represents the liver’s response to injury.

Can this test diagnose cirrhosis? While the test can identify early-stage fibrosis, additional testing is necessary for diagnosing cirrhosis.

How often should the test be performed? Frequency depends on patient-specific conditions as advised by healthcare providers.

Advantages and Disadvantages

This test provides an early detection advantage, ensuring reversible treatments can be timely. However, specialized equipment is required, which might limit immediate availability in some labs. The compatibility with existing analyzers like YR06389 and YR06390 is a notable advantage, but users may need additional training to effectively interpret results.

Use in the Field

In clinical practice, this test is administered to patients with risk factors for liver disease. It aids in patient management decisions by providing objective data on liver fibrosis status, thus optimizing therapy plans and monitoring disease progression over time.

Recommendations

To maximize the utility of the Hepatic Fibrosis Test, ensure proper storage conditions are maintained (2-8°C). Calibration should be done regularly following the 2 or 6-point guidelines. Consider enrolling technical staff in training to better understand the measured parameters and outputs.

Features

• Compatible with multiple Chemiluminescence Immunoassay platforms
• Accurate results with standardized CLIA protocols
• Provides early detection of hepatic fibrosis for improved patient outcomes
• Support for multiple test scenarios with package flexibility (50T/BOX, 100T/BOX, etc.)

Technical Specifications